🇺🇸

Bristol-Myers Squibb makes $12 million investment in Compugen, sets up research partnership

Credit: Proactive Investors- Published on October 11, 2018
US pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY) has agreed to make a $12 million investment in Compugen Ltd (NASDAQ:CGEN), the Israeli drug developer, as part of a new partnership between the companies, which also involves shared cancer trials. The new trials will evaluate the safety and tolerability of Compugen’s...
Advertisement

Recent related videos from verified sources

Researchers Awarded $1 Million Prize At Magee-Womens Research Summit 00:41
Credit: KDKA CBS 2 Pittsburgh - Published on October 10, 2018 


U.S. Investment Rules To Get Tougher Soon 00:58
Credit: Wochit Business - Published on October 10, 2018 


Mega Millions Jackpot Soars To $548 Million 00:24
Credit: WJZ Baltimore - Published on October 10, 2018 


AM Buffalo on the Road - Part 2 Picking out the Perfect Pumpkin 02:30
Credit: Rumble - Published on October 8, 2018 


School Funding Goes Directly Before Florida Voters 00:55
Credit: Wochit News - Published on October 9, 2018 


Kickstarter Campaigns - Barley & Britches (Part 1) | FT Business 02:51
Credit: Financial Times - Published on October 8, 2018 


You might like